August 24, 2023
October 2023 HCPCS Updates – New, Revised, and Discontinued HCPCS Codes and Modifiers
The following information is based on the October 2023 Healthcare Common Procedure Coding System (HCPCS) file. There are several updates that will be effective October 1, 2023. Please keep in mind that the appearance of a HCPCS code is not an indication of coverage by the DME MAC.
This following list contains added HCPCS codes that will be effective October 1, 2023.
HCPCS | DESCRIPTION |
---|---|
A9156 | Oral mucoadhesive, any type (liquid, gel, paste, etc.), per 1 ml |
A9268 | Programmer for transient, orally ingested capsule |
A9269 | Programable, transient, orally ingested capsule, for use with external programmer, per month |
B4148 | Enteral feeding supply kit; elastomeric control fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape |
E0490 | Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by hardware remote |
E0491 | Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by hardware remote, 90-day supply |
J0349 | Injection, rezafungin, 1 mg |
J0801 | Injection, corticotropin (acthar gel), up to 40 units |
J0802 | Injection, corticotropin (ani), up to 40 units |
J0874 | Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg |
J0889 | Daprodustat, oral, 1 mg, (for esrd on dialysis) |
J2359 | Injection, olanzapine, 0.5 mg |
J2781 | Injection, pegcetacoplan, intravitreal, 1 mg |
J7353 | Anacaulase-bcdb, 8.8% gel, 1 gram |
J7519 | Injection, mycophenolate mofetil, 10 mg |
J9051 | Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg |
J9064 | Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg |
J9345 | Injection, retifanlimab-dlwr, 1 mg |
K1036 | Supplies and accessories (e.g., transducer) for low frequency ultrasonic diathermy treatment device, per month |
L1681 | Hip orthosis, bilateral hip joints and thigh cuffs, adjustable flexion, extension, abduction control of hip joint, postoperative hip abduction type, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
L5991 | Addition to lower extremity prostheses, osseointegrated external prosthetic connector |
V2526 | Contact lens, hydrophilic, with blue-violet filter, per lens |
The following HCPCS codes have description/verbiage changes that will be effective October 1, 2023.
HCPCS | DESCRIPTION |
---|---|
A4344 | Indwelling catheter, foley type, two-way, all silicone or polyurethane, each |
J1921 | Injection, labetalol hydrochloride (hikma) not therapeutically equivalent to j1920, 5 mg |
K1004 | Low frequency ultrasonic diathermy treatment device for home use |
K1028 | Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by phone application |
The following listing contains discontinued HCPCS codes, along with the cross-walked HCPCS codes (if applicable). Please note, not all discontinued HCPCS codes will have a cross-walked HCPCS code.
HCPCS | DISCONTINUE DATE | CROSSWALK HCPCS CODE |
---|---|---|
J0800 | 09/30/2023 | None |